A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer

Johnson, PWM, Muers, MF, Peake, MD et al. (5 more authors) (2001) A randomized trial of amifostine as a cytoprotective agent in patients receiving chemotherapy for small cell lung cancer. British Journal of Cancer, 84 (1). pp. 19-24. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2001, Cancer Research Campaign. Reproduced in accordance with the publisher's self-archiving policy. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/.
Keywords: small cell lung cancer; chemotherapy; myelotoxicity; chemoprotection; amifostine; survival
Dates:
  • Published: 5 January 2001
  • Accepted: 13 September 2000
  • Published (online): 3 January 2001
Institution: The University of Leeds
Academic Units: ?? Leeds.DI-LI49 ??
Depositing User: Symplectic Publications
Date Deposited: 06 Sep 2019 08:20
Last Modified: 06 Sep 2019 08:20
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1054/bjoc.2000.1539

Share / Export

Statistics